AAAAAA
Results:
1-24
|
Results: 24
Authors:
Mohty, M
Albat, B
Fegueux, N
Rossi, JF
Citation: M. Mohty et al., Autologous peripheral blood stem cell transplantation following heart transplantation for primary systemic amyloidosis, LEUK LYMPH, 41(1-2), 2001, pp. 221-223
Authors:
Dereure, O
Navarro, R
Rossi, JF
Guilhou, JJ
Citation: O. Dereure et al., Rituximab-induced vasculitis, DERMATOLOGY, 203(1), 2001, pp. 83-84
Authors:
Fabbro-Peray, P
Daures, JP
Rossi, JF
Citation: P. Fabbro-peray et al., Environmental risk factors for non-Hodgkin's lymphoma: a population-based case-control study in Languedoc-Roussillon, France, CANC CAUSE, 12(3), 2001, pp. 201-212
Authors:
Garban, F
Attal, M
Rossi, JF
Payen, C
Fegueux, N
Sotto, JJ
Citation: F. Garban et al., Immunotherapy by non-myeloablative allogeneic stem cell transplantation inmultiple myeloma: results of a pilot study as salvage therapy after autologous transplantation, LEUKEMIA, 15(4), 2001, pp. 642-646
Authors:
Mohty, M
Fegueux, N
Exbrayat, C
Lu, ZY
Legouffe, E
Quittet, P
Lopez-Martinez, E
Latry, P
Avinens, O
Hertog, C
Klein, B
Eliaou, JF
Rossi, JF
Citation: M. Mohty et al., Enhanced graft-versus-tumor effect following dose-reduced conditioning andallogeneic transplantation for refractory lymphoid malignancies after high-dose therapy, BONE MAR TR, 28(4), 2001, pp. 335-339
Authors:
Lavabre-Bertrand, T
Henry, L
Carillo, S
Guiraud, I
Ouali, A
Dutaud, D
Aubry, L
Rossi, JF
Bureau, JP
Citation: T. Lavabre-bertrand et al., Plasma Proteasome Level is a Potential Marker in Patients with Solid Tumors and Hemopoietic Malignancies, CANCER, 92(10), 2001, pp. 2493-2500
Authors:
De Vos, J
Couderc, G
Tarte, K
Jourdan, M
Requirand, G
Delteil, MC
Rossi, JF
Mechti, N
Klein, B
Citation: J. De Vos et al., Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays, BLOOD, 98(3), 2001, pp. 771-780
Authors:
Blaise, D
Attal, M
Reiffers, J
Michallet, M
Bellanger, C
Pico, JL
Stoppa, AM
Payen, C
Marit, G
Bouabdallah, R
Sotto, JJ
Rossi, JF
Brandely, M
Hercend, T
Maraninchi, D
Citation: D. Blaise et al., Randomized study of recombinant interleukin-2 after autologous bone marrowtransplantation for acute leukemia in first complete remission, EUR CYTOKIN, 11(1), 2000, pp. 91-97
Authors:
Mohty, M
Peyriere, H
Guinet, C
Hillaire-Buys, D
Blayac, JP
Rossi, JF
Citation: M. Mohty et al., Carboxypeptidase G2 rescue in delayed methotrexate elimination in renal failure, LEUK LYMPH, 37(3-4), 2000, pp. 441-443
Authors:
Tarte, K
Fiol, G
Rossi, JF
Klein, B
Citation: K. Tarte et al., Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro, LEUKEMIA, 14(12), 2000, pp. 2182-2192
Authors:
Gu, ZJ
De Vos, J
Rebouissou, C
Jourdan, M
Zhang, XG
Rossi, JF
Wijdenes, J
Klein, B
Citation: Zj. Gu et al., Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cellsurvival and growth factors, LEUKEMIA, 14(1), 2000, pp. 188-197
Authors:
Negrier, S
Caty, A
Lesimple, T
Douillard, JY
Escudier, B
Rossi, JF
Viens, P
Gomez, F
Citation: S. Negrier et al., Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil, J CL ONCOL, 18(24), 2000, pp. 4009-4015
Authors:
Cordoba, F
Lavabre-Bertrand, T
Salhi, SL
Huguet, MF
Gerfaux, J
Rossi, JF
Vendrell, JP
Citation: F. Cordoba et al., Spontaneous monoclonal immunoglobulin-secreting peripheral blood mononuclear cells as a marker of disease severity in multiple myeloma, BR J HAEM, 108(3), 2000, pp. 549-558
Authors:
Jourdan, M
Tarte, K
Legouffe, E
Brochier, J
Rossi, JF
Klein, B
Citation: M. Jourdan et al., Tumor necrosis factor is a survival and proliferation factor for human myeloma cells, EUR CYTOKIN, 10(1), 1999, pp. 65-70
Authors:
Klein, B
Lu, ZY
Gu, ZJ
Costes, V
Jourdan, M
Rossi, JF
Citation: B. Klein et al., Interleukin-10 and gp130 cytokines in human multiple myeloma, LEUK LYMPH, 34(1-2), 1999, pp. 63-70
Authors:
Bouabdallah, R
Stoppa, AM
Rossi, JF
Lepeu, G
Coso, D
Xerri, L
Ladaique, P
Chabannon, C
Blaise, D
Bardou, VJ
Alzieu, C
Gastaut, JA
Maraninchi, D
Citation: R. Bouabdallah et al., Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients, LEUKEMIA, 13(6), 1999, pp. 950-956
Authors:
Escudier, B
Chevreau, C
Lasset, C
Douillard, JY
Ravaud, A
Fabbro, M
Caty, A
Rossi, JF
Viens, P
Bergerat, JP
Savary, J
Negrier, S
Citation: B. Escudier et al., Cytokines in metastatic renal cell carcinoma: Is it useful to switch to interleukin-2 or interferon after failure of a first treatment?, J CL ONCOL, 17(7), 1999, pp. 2039-2043
Authors:
Klein, B
Li, XY
Lu, ZY
Jourdan, M
Tarte, K
Brochier, J
Claret, E
Wijdenes, J
Rossi, JF
Citation: B. Klein et al., Activation molecules on human myeloma cells, CURR T MICR, 246, 1999, pp. 335-341
Authors:
Costes, V
Magen, V
Legouffe, E
Durand, L
Baldet, P
Rossi, JF
Klein, B
Brochier, J
Citation: V. Costes et al., The Mi15 monoclonal antibody (anti-Syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens, HUMAN PATH, 30(12), 1999, pp. 1405-1411
Authors:
Tarte, K
Zhang, XG
Legouffe, E
Hertog, C
Mehtali, M
Rossi, JF
Klein, B
Citation: K. Tarte et al., Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells, J IMMUNOL, 163(1), 1999, pp. 514-524
Authors:
Rossi, JF
Citation: Jf. Rossi, Contribution of neurophysiological guidance to stereotactic posteroventralpallidotomy for Parkinson's disease - Comment, ACT NEUROCH, 141(11), 1999, pp. 1201-1201
Authors:
Dechaud, H
Maudelonde, T
Daures, JP
Rossi, JF
Hedon, B
Citation: H. Dechaud et al., Evaluation of endometrial inflammation by quantification of macrophages, Tlymphocytes, and interleukin-1 and -6 in human endometrium, J AS REPROD, 15(10), 1998, pp. 612-618
C-reactive protein serum level is a valuable and simple prognostic marker in norm Hodgkin's lymphoma
Authors:
Legouffe, E
Rodriguez, C
Picot, MC
Richard, B
Klein, B
Rossi, JF
Commes, T
Citation: E. Legouffe et al., C-reactive protein serum level is a valuable and simple prognostic marker in norm Hodgkin's lymphoma, LEUK LYMPH, 31(3-4), 1998, pp. 351-357
Authors:
Costes, V
Portier, M
Lu, ZY
Rossi, JF
Bataille, R
Klein, B
Citation: V. Costes et al., Interleukin-1 in multiple myeloma: producer cells and their role in the control of IL-6 production, BR J HAEM, 103(4), 1998, pp. 1152-1160
Risultati:
1-24
|